Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing HIV/AIDS in correctional settings.

Sandra A Springer1, Frederick L Altice

  • 1Yale University School of Medicine, Yale AIDS Program, Section of Infectious Diseases, 135 College Street, Suite 323, New Haven, CT 06510, USA. sandra.springer@yale.edu

Current HIV/AIDS Reports
|December 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Barriers and facilitators to pre-exposure prophylaxis uptake among high-risk women and men who have sex with men in Georgia: A pre-implementation mixed-methods study using nominal group technique and the COM-B model.

PLOS global public health·2026
Same author

Nurse Practitioner-Led, Same-Day, Pre-exposure Prophylaxis Delivery Program for People Who Inject Drugs in the United States: Findings From a Pilot Randomized Controlled Trial.

The Journal of the Association of Nurses in AIDS Care : JANAC·2026
Same author

Probation as a targeted entry point for scaling up opioid agonist therapies in Moldova using a modified screening, brief intervention and referral to treatment strategy.

PLOS global public health·2026
Same author

Policy changes in opioid agonist therapy and impacts on HIV and hepatitis C prevention in Canadian federal prisons.

Lancet regional health. Americas·2026
Same author

Drug policy changes threaten HIV and HCV control in Georgia.

The lancet. HIV·2026
Same author

Enhancing uptake of the Canadian Prison Needle Exchange Program using a non-randomized stepped-wedge cluster type 1 hybrid implementation trial: The NEXUS study protocol.

Contemporary clinical trials communications·2026
Same journal

IAS 2025: Why Can't I Breastfeed My Baby When Evidence and Lived Experience Say I Can? A Call for Policy Equity for Mothers Living with HIV.

Current HIV/AIDS reports·2026
Same journal

Cytomegalovirus and HIV Co-Infections During Pregnancy and Early Childhood.

Current HIV/AIDS reports·2026
Same journal

HIV Reservoirs in Brain parenchyma and Cerebrospinal Fluid During Suppressive ART: Same-Same or Very Different?

Current HIV/AIDS reports·2026
Same journal

HIV-1 Tat-driven Glutamate Dysregulation: Implications for Cognitive Impairment in HAND.

Current HIV/AIDS reports·2026
Same journal

Central Nervous System HIV Persistence and Clinical Consequences During Suppressive ART.

Current HIV/AIDS reports·2026
Same journal

Expanding PrEP Access Through Decentralized Delivery Models.

Current HIV/AIDS reports·2026
See all related articles

Approximately 25% of US individuals with HIV/AIDS are incarcerated, straining correctional health systems. Effective release programs are crucial for HIV treatment continuity and improved outcomes.

Area of Science:

  • Public Health
  • Epidemiology
  • Correctional Healthcare

Background:

  • High prevalence of HIV/AIDS within the US correctional system.
  • Incarcerated populations exhibit elevated rates of HIV risk behaviors (e.g., substance use, mental illness, homelessness).
  • Correctional settings present unique challenges to HIV care, including comorbidities and logistical constraints.

Purpose of the Study:

  • To highlight the significant burden of HIV/AIDS in correctional facilities.
  • To identify challenges in providing HIV care to incarcerated individuals.
  • To emphasize the need for integrated HIV care and release programs.

Main Methods:

  • Review of HIV/AIDS prevalence and risk factors in incarcerated populations.
  • Analysis of challenges in delivering HIV care within correctional settings.

Related Experiment Videos

  • Examination of the benefits of HIV detection and treatment for prisoners.

    • Main Results:

    • A substantial proportion of individuals living with HIV/AIDS are incarcerated in the US.
    • Correctional systems face significant hurdles in managing HIV and comorbidities.
    • HIV treatment within prisons has demonstrated considerable benefits for affected individuals.

    Conclusions:

    • Effective HIV management in correctional settings is essential for public health.
    • Prisoner release programs must integrate case management, drug treatment, and adherence support.
    • Continuity of highly active antiretroviral therapy (HAART) post-release is critical for sustained positive HIV outcomes.